BeStock  

AptarGroup ATR

US equityMarket cap rank #1511Medical Instruments & Supplies
$140.08 −$0.26 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $140.08 0.00%
Open$142.35
Prev close$140.34
Day range$139.85 – $143.88
Volume868.1K
Market cap$8.88B
P/E (TTM)33.8
Dividend yield1.37%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.02B+6.0% YoY
Operating profit$137.22M-1.3% YoY
Net profit$32.82M-74.3% YoY
Diluted EPS$0.51-73.4% YoY
Free cash flow$97.55M-14.4% YoY
Operating cash flow$167.60M

Revenue, last 8 quarters

$848.1MDec '24$887.3MMar '25$966.0MJun '25$961.1MSep '25$962.7MDec '25$982.9MMar '26$1.0BJun '26$1.0BSep '26

Net profit, last 8 quarters

$100.9MDec '24$78.7MMar '25$111.7MJun '25$127.8MSep '25$74.3MDec '25$72.8MMar '26$88.0MJun '26$32.8MSep '26

Diluted EPS by quarter

1.49Dec '241.17Mar '251.67Jun '251.92Sep '251.13Dec '251.12Mar '261.36Jun '260.51Sep '26

Free cash flow by quarter

$107.7MDec '24$23.4MMar '25$61.0MJun '25$114.0MSep '25$96.2MDec '25$52.7MMar '26$45.6MJun '26$97.6MSep '26

Annual revenue

$2.9BFY20$3.2BFY21$3.3BFY22$3.5BFY23$3.6BFY24$3.8BFY25

Profitability & balance sheet

Gross margin35.8%
Operating margin12.1%
Net margin6.7%
Return on equity9.9%
Return on assets5.2%
Return on invested capital7.6%
Current ratio1.50
Liabilities / assets47.9%
Cash & investments$212.30M
Total debt$1.42B
Net cash (debt)-$1.21B
Free cash flow / sales7.3%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Pharma$454.19M 44.1%
  • Beauty$365.95M 35.5%
  • Closures$209.42M 20.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.02B $1.03B $982.87M $3.78B $962.74M
Total Operating Revenue $1.02B $1.03B $982.87M $3.78B $962.74M
Cost of Revenue $646.20M $660.99M $630.96M $2.37B $624.52M
Gross Profit $372.92M $365.52M $351.91M $1.40B $338.22M
Operating Expense $235.71M $237.38M $243.33M $893.86M $227.90M
Selling and Admin Expenses $160.16M $157.74M $167.60M $606.50M $151.32M
Depreciation & Amortization & Depletion $75.54M $79.64M $75.73M $287.36M $76.58M
-Depreciation & Amortization $75.54M $79.64M $75.73M $287.36M $76.58M
Operating Profit $137.22M $128.14M $108.58M $510.88M $110.32M
Net Non-Operating Interest Income (Expense) -$13.86M -$13.21M -$13.30M -$41.06M -$12.42M
Non-Operating Interest Income $1.93M $2.79M $3.64M $11.68M $4.58M
Non-Operating Interest Expense $15.79M $16.00M $16.94M $52.74M $17.00M
Other Income (Expense) -$63.02M $120,000.00 -$1.51M $21.56M -$6.38M
Gain on Sale of Security -$1.01M $937,000.00 -$1.09M -$483,000.00 -$1.33M
Earnings from Equity Interest $1.11M $1.40M $714,000.00 $33.91M $1.25M
Special Income (Charges) -$60.23M -$1.42M -$1.09M -$9.84M -$4.05M
-Less:Restructuring and Mergern & Acquisition $2.21M $1.42M $1.09M $9.84M $4.05M
-Gain on Sale Of Business -$58.02M – – – –
Other Non-Operating Income (Expenses) -$2.89M -$802,000.00 -$53,000.00 -$2.03M -$2.25M
Pretax Profit $60.33M $115.05M $93.77M $491.38M $91.52M
Tax $27.51M $27.04M $21.00M $98.88M $17.25M
Net Profit $32.82M $88.01M $72.77M $392.50M $74.27M
Profit from Continuing Operations $32.82M $88.01M $72.77M $392.50M $74.27M
Minority Interests $220,000.00 $437,000.00 $93,000.00 -$292,000.00 -$74,000.00
Net Income to Parent Company $32.60M $87.57M $72.67M $392.79M $74.34M
Net Income to Common Stockholders $32.60M $87.57M $72.67M $392.79M $74.34M
Basic EPS $0.51 $1.38 $1.13 $5.97 $1.14
Diluted EPS $0.51 $1.36 $1.12 $5.89 $1.13
Dividend Per Share $0.48 $0.48 $0.48 $1.83 $0.48

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $5.11B $5.13B $5.10B $5.25B $5.25B
Total Current Assets $1.84B $1.83B $1.77B $1.89B $1.89B
Cash and Cash Equivalents & Short-Term Investments $212.30M $197.27M $229.48M $409.53M $409.53M
-Cash and Cash Equivalents $204.18M $190.40M $222.53M $402.42M $402.42M
-Short Term Investments $8.12M $6.86M $6.95M $7.11M $7.11M
Receivables $883.94M $897.66M $833.27M $803.83M $803.83M
-Accounts Receivable $883.94M $897.66M $833.27M $803.83M $803.83M
Inventory $582.61M $580.14M $551.48M $537.85M $537.85M
Other Current Assets $157.95M $159.75M $154.05M $142.35M $142.35M
Total Non-Current Assets $3.27B $3.30B $3.33B $3.36B $3.36B
Net PPE $1.69B $1.71B $1.72B $1.74B $1.74B
-Gross PPE $4.67B $4.68B $4.65B $4.64B $4.64B
-Accumulated Depreciation -$2.97B -$2.97B -$2.93B -$2.90B -$2.90B
Investments and Advances $132.87M $134.75M $130.76M $131.03M $131.03M
-Available for Sale Securities $11.41M $15.33M $14.49M $16.48M $16.48M
-Long Term Equity Investment $121.46M $119.43M $116.28M $114.55M $114.55M
Goodwill and Other Intangible Assets $1.29B $1.30B $1.32B $1.33B $1.33B
-Goodwill $1.07B $1.07B $1.07B $1.08B $1.08B
-Other Intangible Assets $224.53M $233.74M $244.51M $255.34M $255.34M
Other Non-Current Assets $155.47M $153.23M $159.52M $152.71M $152.71M
Total Liabilities $2.45B $2.46B $2.42B $2.54B $2.54B
Total Current Liabilities $1.22B $1.14B $1.06B $1.17B $1.17B
Short-Term Debt and Capital Lease Obligation $350.68M $249.24M $222.17M $343.53M $343.53M
-Current Debt $350.68M $249.24M $222.17M $343.53M $343.53M
Total Non-Current Liabilities $1.23B $1.32B $1.36B $1.37B $1.37B
Long Term Debt and Capital Lease Obligation $1.07B $1.16B $1.19B $1.19B $1.19B
-Long Term Debt $1.02B $1.12B $1.14B $1.14B $1.14B
-Long Term Capital Lease Obligation $42.94M $43.91M $44.01M $47.94M $47.94M
Non-Current Deferred Liabilities $16.49M $17.23M $17.29M $19.65M $19.65M
Employee Benefits $67.79M $66.14M $64.15M $67.60M $67.60M
Other Non-Current Liabilities $75.68M $76.53M $91.69M $99.43M $99.43M
Total Equity $2.66B $2.67B $2.67B $2.71B $2.71B
Stockholders' Equity $2.61B $2.63B $2.63B $2.67B $2.67B
Capital Stock $732,000.00 $732,000.00 $731,000.00 $728,000.00 $728,000.00
-Common Stock $732,000.00 $732,000.00 $731,000.00 $728,000.00 $728,000.00
Additional Paid-In Capital $1.20B $1.19B $1.19B $1.17B $1.17B
Retained Earnings $2.74B $2.74B $2.68B $2.64B $2.64B
Less: Treasury Stock -$1.13B -$1.10B -$1.05B -$954.32M -$954.32M
Gains/Losses Not Affecting Retained Earnings -$205.66M -$207.33M -$198.72M -$186.38M -$186.38M
Minority Interests $46.86M $46.15M $44.76M $44.13M $44.13M
Payables – – – $340.56M $340.56M
-Accounts Payable – – – $340.56M $340.56M
Current Accrued Expenses – – – $174.93M $174.93M
Current Deferred Liabilities – – – $74.83M $74.83M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $167.60M $103.49M $118.69M $570.00M $183.69M
Net cash flow from continuing operations $167.60M $103.49M $118.69M $570.00M $183.69M
Net Income from Continuing Operations $32.82M $88.01M $72.77M $392.50M $74.27M
Gain/Loss from Continuing Operations $56.64M $2.73M $2.81M -$20.65M $1.71M
Depreciation & Depletion & Amortization $75.54M $79.64M $75.73M $287.36M $76.58M
Deferred Tax -$2.16M $1.47M -$4.57M -$11.69M $20.16M
Change in Working Capital -$12.57M -$75.23M -$47.44M -$125.45M -$502,000.00
-Change in Receivables -$2.39M -$66.31M -$33.03M -$73.89M -$7.08M
-Change in Inventory -$8.52M -$31.24M -$16.94M -$10.65M $12.14M
-Change in Prepaid Assets $1.03M -$6.55M -$12.39M $4.96M $33.02M
-Change in Payables and Accrued Expense -$6.38M $24.73M $36.53M -$27.35M -$33.02M
-Change In Other Working Capital $3.69M $4.12M -$21.60M -$18.52M -$5.57M
Net cash flow from investing -$100.71M -$56.79M -$65.10M -$331.43M -$116.31M
Net Cash Flow from Continuing Investing Activities -$100.71M -$56.79M -$65.10M -$331.43M -$116.31M
Capital Expenditure -$69.01M -$57.56M -$65.40M -$270.42M -$86.82M
Net PPE Purchase and Sale -$1.09M $1.31M $1.33M $3.55M $1.44M
Net Intangibles Purchase and Sale -$1.04M -$301,000.00 -$592,000.00 -$5.02M -$719,000.00
Net Business Purchase and Sale -$29.98M – – -$60.20M -$31.98M
Net Investment Purchase and Sale -$1.35M -$5,000.00 -$103,000.00 -$2.89M $1.55M
Net Other Investing Changes $1.76M -$71,000.00 -$335,000.00 $3.56M $219,000.00
Financing Cash Flow -$49.18M -$77.95M -$230.34M -$77.47M $76.76M
Net Cash Flow from Continuing Financing Activities -$49.18M -$77.95M -$230.34M -$77.47M $76.76M
Net Issuance Payments Of Debt $7.91M $2.71M -$115.86M $394.06M $284.57M
Net Common Stock Issuance -$30.00M -$50.00M -$99.97M -$365.01M -$175.00M
Cash Dividends Paid -$30.52M -$30.61M -$30.92M -$120.78M -$31.50M
Proceeds from Stock Option Exercised $3.44M $465,000.00 $18.52M $18.89M $4.02M
Net Other Financing Charges -$6,000.00 -$510,000.00 -$2.11M -$4.63M -$5.34M
Ending Cash Balance $206.60M $192.83M $224.95M $404.85M $404.85M
Net Change in Cash $17.71M -$31.25M -$176.75M $161.10M $144.14M
Beginning Cash Balance $192.83M $224.95M $404.85M $224.34M $257.06M
Effect of Exchange Rate Changes -$3.93M -$877,000.00 -$3.15M $19.40M $3.15M
Free Cash Flow $97.55M $45.62M $52.71M $294.56M $96.16M

Discussion

No comments yet — be the first to weigh in on ATR.

Sign in to join the discussion.

Scroll to Top